School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, P.R. China.
Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, P.R. China.
Nat Prod Res. 2022 Jan;36(2):595-600. doi: 10.1080/14786419.2020.1795855. Epub 2020 Jul 21.
A novel alkaloid identified as methyl 8,9-dihydroxy-11-oxo-6,11-dihydro-5H-benzo[d]pyrrolo[1,2-a]azepine-3-carboxylate, named portulacatone A () with six known compounds Oleracein E (), 6,7-dihdroxy-3,4-dihydro-2H-isoquinolin-1-one (), ---coumaroytyramine (), 9H-carbazole (), isoaspergin () and flavoglaucin () were obtained from L., while compounds () were isolated from the plant for the first time. The new structure was identified by using UHPLC-ESI-Q-TOF/MS, 1D, 2D NMR and the others were proved by H-NMR and C NMR that comparing with previous reports. It was suggested that the portulacatone A () can significantly inhibit the inflammatory factor, interleukin-1β (IL-1β) in the RAW 264.7 cells induced by LPS.
从 L.中分离得到了一个新的生物碱,命名为甲基 8,9-二羟基-11-氧代-6,11-二氢-5H-苯并[d]吡咯并[1,2-a]氮杂卓-3-羧酸甲酯(),同时还得到了 6 个已知化合物:Oleracein E()、6,7-二羟基-3,4-二氢-2H-异喹啉-1-酮()、---咖啡酰基酪氨酸()、9H-咔唑()、异aspergin()和 flavoglaucin()。新化合物的结构通过 UHPLC-ESI-Q-TOF/MS、1D、2D NMR 等方法确定,而其他化合物则通过与以往报道的 H-NMR 和 C-NMR 比较来证明。研究表明,portulacatone A()可以显著抑制 LPS 诱导的 RAW 264.7 细胞中炎症因子白细胞介素-1β(IL-1β)的产生。